Cargando…
Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1
Glioblastoma (GBM) is the most common brain tumor with poor survival rate. Our results show that penfluridol, an antipsychotic drug significantly reduced the survival of ten adult and pediatric glioblastoma cell lines with IC(50) ranging 2–5 μM after 72 hours of treatment and induced apoptosis. Penf...
Autores principales: | Ranjan, Alok, Srivastava, Sanjay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464842/ https://www.ncbi.nlm.nih.gov/pubmed/28380428 http://dx.doi.org/10.18632/oncotarget.16515 |
Ejemplares similares
-
Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth
por: Ranjan, Alok, et al.
Publicado: (2017) -
Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis
por: Ranjan, Alok, et al.
Publicado: (2016) -
Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis
por: Srivastava, Suyash, et al.
Publicado: (2020) -
Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
por: Kim, Hyungsin, et al.
Publicado: (2019) -
Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
por: Hu, Jiahao, et al.
Publicado: (2022)